At a glance
- Originator Hassle Lakemedel
- Class Antihypertensives; Propanolamines; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 06 Jan 2003 No development reported - Phase-I for Arrhythmias in Sweden (unspecified route)
- 22 Aug 2000 Astra Hässle is now called Hässle Läkemedel
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed